Codex DNA Inc

NASDAQ:DNAY  
1.38
+0.02 (+1.47%)
4:09:22 PM EDT: $1.35 -0.03 (-2.09%)
Positive Earnings Pre-Announcement

Telesis Bio Reports Third Quarter 2022 Financial Results

Published: 11/08/2022 22:49 GMT
Codex DNA Inc (DNAY) - Telesis Bio Inc. Reports Third Quarter 2022 Financial Results.
Codex Dna Inc Sees FY Revenue $23.0 Million to $25.0 Million.
Codex Dna Inc Q3 Revenue Rose 140 Percent to $6.7 Million.
Codex Dna Inc - Increases Revenue Guidance to $23 Million to $25 Million for Full Year Fiscal 2022.
Codex Dna Inc - Qtrly Loss per Share $0.42.
Codex Dna Inc - Cash on Hand is Anticipated to Be Approximately $40 Million at End of 2022.
Codex Dna Inc - As of September 30, 2022, Company Had $49.9 Million in Cash, Restricted Cash, Cash Equivalents and Short-term Investments.
Revenue is expected to be $6.3 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $7.2 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.